iTeos Therapeutics, Inc. (ITOS) NASDAQ

10.18

+0.02(+0.20%)

Updated at July 03 04:00PM

Currency In USD

Valuation

Market Cap310.84M
Enterprise Value173.81M
P/E Ratio-3.37
PEG Ratio-0.42
Price/Sales Ratio11.13
Price/Book Ratio0.78
Enterprise/Revenue6.8
Enterprise/EBITDA-1.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-3.74
Operating Margin-4.35

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.21

Income Statement

Revenue35M
Revenue/Share0.81
Gross Profit33.76M
EBITDA-159.53M
Net Income-134.41M
Diluted EPS-3.32

Balance Sheet

Total Cash520.37M
Total Cash/Share12.03
Total Debt5.05M
Total Debt/Equity0.01
Current Ratio14.13
Book Value Per Share13.03

Price History

52-Week Change-27.39
52-Week High18.13
52-Week Low4.8
Moving Average 50 Days8.85
Moving Average 200 Days8.2

Statistics

Average Volume1.39M
Shares Outstanding38.27M
% Held by Institutions78.49

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A